content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Brainstorm Cell Therapeutics Inc. (BCLI)
0.02
(2.00%)
content_middle
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinsons disease, and multiple sclerosis. It holds rights to develop and commercialize its NurOwn technology through a worldwide licensing agreement with Ramot, the technology transfer company of the Tel Aviv University.
BCLI's NurOwn technology, an autologous adult stem cell therapy technology that differentiates bone marrow-derived mesenchymal stem cells into specialized neuron-supporting cells. It also has agreements with Hadasit Medical Research Services and Development Ltd. to conduct its ALS clinical trials at the Hadassah Medical Center.
Brainstorm Cell Therapy was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. BCLI was founded in 2000 and is based in New York, New York.
Previous Close:
0.53
Open:
4.31
Bid:
4.20
Ask:
4.49
1yr Target Price:
9.00
Day's Range:
4.20 - 4.33
52wk Range:
0.14 - 3.35
Volume:
51022
Average Daily Volume:
110611
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- April 2, 2024 - 3:16pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q3
- August 18, 2023 - 4:09pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings
- May 27, 2023 - 12:37pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q1
- April 10, 2023 - 4:40pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- November 10, 2022 - 9:42am | Out and About, Research Notes, Out and About
- August 16, 2022 - 11:38am | Out and About, Research Notes, Out and About
- May 3, 2022 - 10:45am | Out and About, Research Notes, Out and About
- February 8, 2022 - 8:07am
- September 23, 2021 - 7:10pm | Out and About, Research Notes, Out and About, Earnings Q2
- February 22, 2021 - 12:39pm | Out and About, Research Notes, Out and About
- May 30, 2020 - 9:44am | Out and About, Research Notes, Out and About, Earnings Q1
- April 11, 2020 - 1:23pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- March 6, 2020 - 10:04am | Out and About, Out and About, Financings
- September 11, 2018 - 1:18pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q2
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- March 10, 2017 - 12:00am | Earnings, Earnings Q4